123 related articles for article (PubMed ID: 38838952)
1. Plasma levels of complement components C5 and C9 are associated with thrombin generation.
Vacik Díaz R; Munsch G; Iglesias MJ; Pallares Robles A; Ibrahim-Kosta M; Nourse J; Khan E; Castoldi E; Saut N; Boland A; Germain M; Deleuze JF; Odeberg J; Morange PE; Danckwardt S; Tregouët DA; Goumidi L
J Thromb Haemost; 2024 Jun; ():. PubMed ID: 38838952
[TBL] [Abstract][Full Text] [Related]
2. A Conformational Change of Complement C5 Is Required for Thrombin-Mediated Cleavage, Revealed by a Novel Ex Vivo Human Whole Blood Model Preserving Full Thrombin Activity.
Nilsson PH; Johnson C; Quach QH; Macpherson A; Durrant O; Pischke SE; Fure H; Landsem A; Bergseth G; Schjalm C; Haugaard-Kedström LM; Huber-Lang M; van den Elsen J; Brekke OL; Mollnes TE
J Immunol; 2021 Sep; 207(6):1641-1651. PubMed ID: 34380648
[TBL] [Abstract][Full Text] [Related]
3. Secretion of the terminal complement proteins, C5-C9, by human platelets.
Houle JJ; Leddy JP; Rosenfeld SI
Clin Immunol Immunopathol; 1989 Mar; 50(3):385-93. PubMed ID: 2917425
[TBL] [Abstract][Full Text] [Related]
4. Thrombin generation as an intermediate phenotype for venous thrombosis.
Segers O; van Oerle Rv; ten Cate Ht; Rosing J; Castoldi E
Thromb Haemost; 2010 Jan; 103(1):114-22. PubMed ID: 20062924
[TBL] [Abstract][Full Text] [Related]
5. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
[TBL] [Abstract][Full Text] [Related]
6. Functional analysis of a complement polymorphism (rs17611) associated with rheumatoid arthritis.
Giles JL; Choy E; van den Berg C; Morgan BP; Harris CL
J Immunol; 2015 Apr; 194(7):3029-34. PubMed ID: 25725109
[TBL] [Abstract][Full Text] [Related]
7. C3-independent immune haemolysis: haemolysis of EAC14oxy2 cells by C5-C9 without participation of C3.
Kitamura H; Matsumoto M; Nagaki K
Immunology; 1984 Nov; 53(3):575-82. PubMed ID: 6237987
[TBL] [Abstract][Full Text] [Related]
8. Thrombin Generation Assay and Its Application in the Clinical Laboratory.
Tripodi A
Clin Chem; 2016 May; 62(5):699-707. PubMed ID: 26955824
[TBL] [Abstract][Full Text] [Related]
9. Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited and released from Salmonella minnesota S218 without causing bacterial death.
Joiner KA; Hammer CH; Brown EJ; Cole RJ; Frank MM
J Exp Med; 1982 Mar; 155(3):797-808. PubMed ID: 6801179
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of the membrane attack mechanism of complement.
Kolb WP; Haxby JA; Arroyave CM; Müller-Eberhard HJ
J Exp Med; 1972 Mar; 135(3):549-66. PubMed ID: 5058233
[TBL] [Abstract][Full Text] [Related]
11. Single nucleotide polymorphisms in an intergenic chromosome 2q region associated with tissue factor pathway inhibitor plasma levels and venous thromboembolism.
Dennis J; Truong V; Aïssi D; Medina-Rivera A; Blankenberg S; Germain M; Lemire M; Antounians L; Civelek M; Schnabel R; Wells P; Wilson MD; Morange PE; Trégouët DA; Gagnon F
J Thromb Haemost; 2016 Oct; 14(10):1960-1970. PubMed ID: 27490645
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism of the complement 5 gene and cardiovascular outcome in patients with atherosclerosis.
Hoke M; Speidl W; Schillinger M; Minar E; Zehetmayer S; Schönherr M; Wagner O; Mannhalter C
Eur J Clin Invest; 2012 Sep; 42(9):921-6. PubMed ID: 22452399
[TBL] [Abstract][Full Text] [Related]
13. Thrombin generates previously unidentified C5 products that support the terminal complement activation pathway.
Krisinger MJ; Goebeler V; Lu Z; Meixner SC; Myles T; Pryzdial EL; Conway EM
Blood; 2012 Aug; 120(8):1717-25. PubMed ID: 22802338
[TBL] [Abstract][Full Text] [Related]
14. The human complement system in thrombin-mediated platelet function.
Polley MJ; Nachman R
J Exp Med; 1978 Jun; 147(6):1713-26. PubMed ID: 681879
[TBL] [Abstract][Full Text] [Related]
15. Risk of non-Hodgkin lymphoma in association with germline variation in complement genes.
Cerhan JR; Novak AJ; Fredericksen ZS; Wang AH; Liebow M; Call TG; Dogan A; Witzig TE; Ansell SM; Habermann TM; Kay NE; Slager SL
Br J Haematol; 2009 Jun; 145(5):614-23. PubMed ID: 19344414
[TBL] [Abstract][Full Text] [Related]
16. Concizumab, an anti-tissue factor pathway inhibitor antibody, induces increased thrombin generation in plasma from haemophilia patients and healthy subjects measured by the thrombin generation assay.
Waters EK; Sigh J; Friedrich U; Hilden I; Sørensen BB
Haemophilia; 2017 Sep; 23(5):769-776. PubMed ID: 28594458
[TBL] [Abstract][Full Text] [Related]
17. Preanalytic processing of rat plasma influences thrombin generation and fibrinolysis assays.
Brooks MB; Stablein AP; Johnson L; Schultze AE
Vet Clin Pathol; 2017 Sep; 46(3):496-507. PubMed ID: 28841240
[TBL] [Abstract][Full Text] [Related]
18. Human complement in thrombin-mediated platelet function: uptake of the C5b-9 complex.
Polley MJ; Nachman RL
J Exp Med; 1979 Sep; 150(3):633-45. PubMed ID: 479764
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of complement component C5 prevents clotting in an ex vivo model of xenogeneic activation of coagulation.
Rataj D; Werwitzke S; Haarmeijer B; Winkler M; Ramackers W; Petersen B; Niemann H; Wünsch A; Bähr A; Klymiuk N; Wolf E; Abicht JM; Ayares D; Tiede A
Xenotransplantation; 2016 Mar; 23(2):117-27. PubMed ID: 26773447
[TBL] [Abstract][Full Text] [Related]
20. Studies on the mechanism of bacterial resistance to complement-mediated killing. II. C8 and C9 release C5b67 from the surface of Salmonella minnesota S218 because the terminal complex does not insert into the bacterial outer membrane.
Joiner KA; Hammer CH; Brown EJ; Frank MM
J Exp Med; 1982 Mar; 155(3):809-19. PubMed ID: 6801180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
